Related references
Note: Only part of the references are listed.Primary Human Hepatocyte Spheroid Model as a 3D In Vitro Platform for Metabolism Studies
Kajsa P. Kanebratt et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
In Defense of Current Concepts and Applications of Clearance in Drug Development and Therapeutics
Malcolm Rowland et al.
DRUG METABOLISM AND DISPOSITION (2021)
Insulin-dependent glucose consumption dynamics in 3D primary human liver cultures measured by a sensitive and specific glucose sensor with nanoliter input volume
Aurino M. Kemas et al.
FASEB JOURNAL (2021)
Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data
Jaydeep Yadav et al.
DRUG METABOLISM REVIEWS (2021)
Successful and Unsuccessful Prediction of Human Hepatic Clearance for Lead Optimization
Jasleen K. Sodhi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Conditions for maintenance of hepatocyte differentiation and function in 3D cultures
Niklas Handin et al.
ISCIENCE (2021)
Primary Human Hepatocyte Spheroids as an In Vitro Tool for Investigating Drug Compounds with Low Hepatic Clearance
Julia Riede et al.
DRUG METABOLISM AND DISPOSITION (2021)
Utility of Three-Dimensional Cultures of Primary Human Hepatocytes (Spheroids) as Pharmacokinetic Models
Kenta Mizoi et al.
BIOMEDICINES (2020)
Determination of low intrinsic clearance in vitro: the benefit of a novel internal standard in human hepatocyte incubations
Ugo Zanelli et al.
XENOBIOTICA (2019)
3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity: Emerging Culture Paradigms and Applications
Volker M. Lauschke et al.
BIOTECHNOLOGY JOURNAL (2019)
Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac (vol 41, pg 2024, 2013)
Tom S. Chan et al.
DRUG METABOLISM AND DISPOSITION (2019)
Use of Segregated Hepatocyte Scaling Factors and Cross-Species Relationships to Resolve Clearance Dependence in the Prediction of Human Hepatic Clearance
D. Hallifax et al.
DRUG METABOLISM AND DISPOSITION (2019)
Improving Prediction of Metabolic Clearance Using Quantitative Extrapolation of Results Obtained From Human Hepatic Micropatterned Cocultures Model and by Considering the Impact of Albumin Binding
Franck Da-silva et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Comparison of methods for the prediction of human clearance from hepatocyte intrinsic clearance for a set of reference compounds and an external evaluation set
Tetsuo Yamagata et al.
XENOBIOTICA (2017)
Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics
Sabine U. Vorrink et al.
FASEB JOURNAL (2017)
Metabolic Profiling of Human Long-Term Liver Models and Hepatic Clearance Predictions from In Vitro Data Using Nonlinear Mixed-Effects Modeling
Nicole A. Kratochwil et al.
AAPS JOURNAL (2017)
Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates
Volker M. Lauschke et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
Valentina Cappello et al.
SCIENTIFIC REPORTS (2016)
Determination of Human Hepatocyte Intrinsic Clearance for Slowly Metabolized Compounds: Comparison of a Primary Hepatocyte/Stromal Cell Co-culture with Plated Primary Hepatocytes and HepaRG
Britta Bonn et al.
DRUG METABOLISM AND DISPOSITION (2016)
Addressing the Challenges of Low Clearance in Drug Research
Li Di et al.
AAPS JOURNAL (2015)
Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the In vitro-In vivo extrapolation methods: Emphasis on an apparent fraction unbound in liver for drugs
Patrick Poulin
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
A Perspective on the Prediction of Drug Pharmacokinetics and Disposition in Drug Research and Development
Li Di et al.
DRUG METABOLISM AND DISPOSITION (2013)
A comprehensive evaluation of metabolic activity and intrinsic clearance in suspensions and monolayer cultures of cryopreserved primary human hepatocytes
Cornelia M. Smith et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Practical use of the regression offset approach for the prediction of in vivo intrinsic clearance from hepatocytes
Anna-Karin Sohlenius-Sternbeck et al.
XENOBIOTICA (2012)
A Novel Relay Method for Determining Low-Clearance Values
Li Di et al.
DRUG METABOLISM AND DISPOSITION (2012)
Human Pharmacokinetic Prediction of UDP-Glucuronosyltransferase Substrates with an Animal Scale-Up Approach
Tsuneo Deguchi et al.
DRUG METABOLISM AND DISPOSITION (2011)
Primary Human Hepatocytes on Biodegradable Poly(I-Lactic acid) Matrices: A Promising Model for Improving Transplantation Efficiency With Tissue Engineering
Eva Toeroek et al.
LIVER TRANSPLANTATION (2011)
Prediction of Human Metabolic Clearance from In Vitro Systems: Retrospective Analysis and Prospective View
David Hallifax et al.
PHARMACEUTICAL RESEARCH (2010)
Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds
A. -K. Sohlenius-Sternbeck et al.
XENOBIOTICA (2010)
Prediction of drug distribution within blood
Paulo Paixao et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Hepatocellular binding of drugs: Correction for unbound fraction in hepatocyte incubations using microsomal binding or drug lipophilicity data
Peter J. Kilford et al.
DRUG METABOLISM AND DISPOSITION (2008)
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds
R. Scott Obach et al.
DRUG METABOLISM AND DISPOSITION (2008)
Reliability of human cryopreserved hepatocytes and liver microsomes as in vitro systems to predict metabolic clearance
R. Stringer et al.
XENOBIOTICA (2008)
Mechanistic approaches to volume of distribution predictions: Understanding the processes
Trudy Rodgers et al.
PHARMACEUTICAL RESEARCH (2007)
Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance
Hayley S. Brown et al.
DRUG METABOLISM AND DISPOSITION (2007)
Orosomucoid (α1-acid glycoprotein) plasma concentration and genetic variants:: Effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation
Sara Colombo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes
RJ Riley et al.
DRUG METABOLISM AND DISPOSITION (2005)
The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties
RP Austin et al.
DRUG METABOLISM AND DISPOSITION (2002)
Share Paper
